Hey #ScienceTwitter; is there a circRNA array/sequencing company/platform that you recommend? And are there any companies out there that synthesize custom cirRNAs?
With our publication in @NatureMedicine on pandemic-related barriers to the success of women in research, I’d like to shine a spotlight on gender equity for women physician-scientists, who face cumulative barriers imposed in medicine AND science https://t.co/7TlbyIsHAp 1/n
Harry's review article "Casimersen for Duchenne muscular dystrophy" is featured in the latest issue of #DrugsofToday@clarivate, summarizing the preclinical and clinical data currently available for casimersen, emphasizing pharmacokinetics and safety. @WCHRIUofA@UAlberta_FoMD
A pleasure to see that the @journal_nd special issue celebrating Terry Partridge’s contributions to muscle research and mentorship is out. https://t.co/lBhKoYVsm0 Thanks Raju for co-editing, @LochmullerLab, @JenniferEMorgan, Carsten and JND team for help and Pete Zammit for👇
@davidjglassMD I very much miss the Molecular Mechanisms of Muscle Wasting during aging and disease in Ascona, and I hope it will be back soon. Great atmosphere for connecting with other scientists, and the view isn't too bad either!
Together with Isabelle Richard @GenethonFr we describe a mouse model that mimics #LGMD2L muscle symptoms, offers insights into the basis of this disease, and test potential therapies https://t.co/JF5hwRkVbI.
50 free copies of our article are available below!: Restoration of dystrophin expression and correction of #Duchenne muscular dystrophy by genome editing https://t.co/MpZWQuIu80 @tandfonline@UAlberta_FoMD#CRISPR
This.
If I had continued in the cure mindset for my son’s Duchenne diagnosis, I would have wasted 7.5 years of his life so far being unhappy.
Accept and adapt. Let it go. Move forward. Smile.
#Duchenne#DMD#Disability
Delighted to co-host the new Research Topic "Genome and Transcriptome Editing to Understand and Treat Neuromuscular Diseases" with @RikaMaruyama_E@AlysonAFiorillo@MacGyver0282 and Dr. Duan in Frontiers in Genome Editing
@FrontGenEditing
https://t.co/Zt5JN9mA6j #CRISPR